Capital Market Innovation Services Forum


8:30 AM-9:15 AM
  • 主题报告1
  • Keynote Speech1
  • 中国后疫情时代医药行业展望
  • The Outlook of China's Pharmaceutical Industry in the Post-Covid-19 Era
  • 毛化, 弗若斯特沙利文咨询公司合伙人
  • Fred MAO, Partner, Frost & Sullivan
9:15 AM-10:00 AM
  • 主题报告2
  • Keynote Speech2
  • 生物科技企业上市财税关注重点
  • IPO Accounting Issues for Biotech and Pharmaceutical Companies
  • 杨淑娟，安永北京主管合伙人&大中华区政府及公共服务事业部主管合伙人
  • Jane YANG，Beijing Chief Managing Partner and Government&Pulic Service Market Segment Leader of Greater China Assurance Partner,Ernst&Young Hua Ming LLC
10:00 AM-10:45 AM
  • 主题报告3
  • Keynote Speech3
  • 波动市场下的价值之“锚”——医疗行业资本运作趋势展望
  • The "anchor" of value in fluctuating market -- Prospect of capital operation trend of medical indust
  • 高元，华泰联合大健康部主管兼业务四部主管，董事总经理
  • GAO yuan, Managing Director，Head of healthcare department，Huatai United Securities
10:45 AM-11:30 AM
  • 圆桌讨论1
  • Panel 1
  • 港交所拟引入SPAC机制：机遇与挑战
  • HKEX is about to Introducing SPAC mechanism: Opportunities and Challenges
    • Moderator
  • 费凡, 安永大中华区生命科学与医疗健康行业联席主管合伙人，华中地区审计部副主管审计服务主管合伙人
  • Felix FEI, Ernst & Young ，Health Science and Wellness Sector Co-leader, Greater China，Deputy Assurance Leader, China Central Partner, Assurance
    • Panelists
  • 毛化, 弗若斯特沙利文咨询公司合伙人
  • Fred MAO, Partner, Frost & Sullivan
11:30 PM-12:15 PM
  • 圆桌讨论2
  • Panel 2
  • 北交所上市规则解读
  • Interpretation of IPO rules of Beijing Stock Exchange
    • Panelists
  • 诸斌, 安永税务与商务咨询合伙人
  • Raymond ZHU, Tax & Business Advisory Partner of EY
  • 高元, 华泰联合大健康部主管兼业务四部主管，董事总经理
  • GAO yuan, Managing Director，Head of healthcare department，Huatai United Securities
  • 毛化, 弗若斯特沙利文咨询公司合伙人
  • Fred MAO, Partner, Frost & Sullivan
  • 傅扬远, 嘉源律师事务所高级合伙人
  • FU Yangyuan，Senior partner, JIA YUAN LAW OFFICES, Senior partner
Specification:
  • Released: September 17, 2020
  • Last update: September 19, 2020
  • Version: 1.1